TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33345816

Group type: EXPERIMENTAL
Intervention: Intravenous protocol (intravenous paracetamol 3 times daily with oral ibuprofen twice daily)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Oral protocol (oral paracetamol 3 times daily with oral ibuprofen twice daily)
Number of subjects: 127

Group type: COMPARATOR
Intervention: On-demand protocol (oral paracetamol or ibuprofen or dipyrone based on visual analog scale)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Intravenous protocol
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Oral protocol
Number of subjects: 127

Group type: COMPARATOR
Intervention: On-demand protocol
Number of subjects: 127
Study: 35367870

Group type: EXPERIMENTAL
Intervention: Low-fat diet (F, 20% carbohydrates, 60% fat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-carbohydrate diet (C, 35% carbohydrates, 45% fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-fat diet (F) in subjects with rare variant in LPL gene
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-carbohydrate diet (C) in subjects with rare variant in LPL gene
Number of subjects: 12
Study: 33245749

Group type: EXPERIMENTAL
Intervention: CDR132L (0.32, 1, 3, and 10 mg/kg body weight)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CDR132L (≥1 mg/kg)
Number of subjects: 28
Study: 33472201

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) until the 36th week of gestation
Number of subjects: 278

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 278
Study: 35525940

Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interactive lecture (IL)
Number of subjects: 0
Study: 36155316

Group type: EXPERIMENTAL
Intervention: Oral health intervention for 24 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 66
Study: 33373708

Group type: EXPERIMENTAL
Intervention: iTind
Number of subjects: 175

Group type: COMPARATOR
Intervention: sham
Number of subjects: 175
Study: 32764918

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 100μg/vilanterol (VI) 25μg
Number of subjects: 16485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16485
Study: 33742775

Group type: EXPERIMENTAL
Intervention: 12 h modified N-acetylcysteine (NAC) regimen
Number of subjects: 45

Group type: COMPARATOR
Intervention: 20.25 h standard N-acetylcysteine (NAC) regimen
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Baseline plasma APAP and purine metabolites
Number of subjects: 45
Study: 33726695

Group type: EXPERIMENTAL
Intervention: Geriatric case management
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Standard care (care as usual)
Number of subjects: 3200
Study: 35462610

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 201
Study: 33012187

Group type: EXPERIMENTAL
Intervention: Busulfan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IFN‐α
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imetelstat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New experimental drugs and drug combinations
Number of subjects: 0
Study: 35385366

Group type: EXPERIMENTAL
Intervention: Online learning only
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Online learning with the use of specimen equine bones
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Learning on conventional radiographs with specimen equine bones
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 83
Study: 33977736

Group type: EXPERIMENTAL
Intervention: Celecoxib combined with OxyContin and Pregabalin (experimental group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: OxyContin combined with Pregabalin (control group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Tamsulosin hydrochloride sustained-release capsules (for urinary dysfunction in both groups)
Number of subjects: 51
Study: 32708894

Group type: EXPERIMENTAL
Intervention: Ibuprofen (2 × 00 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 33684963

Group type: EXPERIMENTAL
Intervention: Improvisational theatre exercises (45-minute communication-focused intervention)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control arm without intervention
Number of subjects: 188
Study: 33340917

Group type: EXPERIMENTAL
Intervention: 6-week online Cognitive Behavioral Therapy for Insomnia (CBT-I) program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Six weeks of online psychoeducational modules on insomnia and grief (Control)
Number of subjects: 30
Study: 34963177

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (Group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional surgery (Group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 150
Study: 33066973

Group type: EXPERIMENTAL
Intervention: Elagolix 150 mg once daily for 6 months
Number of subjects: 1686

Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg twice daily for 6 months
Number of subjects: 1686

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1686
Study: 32691110

Group type: EXPERIMENTAL
Intervention: Direct methods group using a straight line from the anal verge to the tumor
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Direct mass method (recommended)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lower end of the external anal sphincter as a landmark
Number of subjects: 50
Study: 32488233

Group type: EXPERIMENTAL
Intervention: HUMMUS
Number of subjects: 39

Group type: COMPARATOR
Intervention: BARS
Number of subjects: 39

Group type: COMPARATOR
Intervention: NO SNACK
Number of subjects: 39
Study: 35026855

Group type: EXPERIMENTAL
Intervention: Telementoring
Number of subjects: 23

Group type: COMPARATOR
Intervention: In-person training
Number of subjects: 23
Study: 34366847

Group type: EXPERIMENTAL
Intervention: TQ-F3083 (2 to 160 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TQ-F3083 (multiple doses for 7 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TQ-F3083 (after high-fat and high-calorie breakfast)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TQ-F3083
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TQ-F3083 (20–160 mg cohorts)
Number of subjects: 60
Study: 32596199

Group type: EXPERIMENTAL
Intervention: Movement microbreaks during work hours
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 43
Study: 35227219

Group type: EXPERIMENTAL
Intervention: Underbody forced-air warming (FAW) blankets
Number of subjects: 100

Group type: COMPARATOR
Intervention: Overbody forced-air warming (FAW) blankets
Number of subjects: 100
Study: 33206193

Group type: EXPERIMENTAL
Intervention: e‐cigarette group (125 participants)
Number of subjects: 186

Group type: COMPARATOR
Intervention: control group (61 participants)
Number of subjects: 186
Study: 34494204

Group type: EXPERIMENTAL
Intervention: Fluid challenge over 10 minutes (FC10)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fluid challenge over 20 minutes (FC20)
Number of subjects: 49
Study: 33848758

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: Combination NRT
Number of subjects: 896

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 896
Study: 36329525

Group type: EXPERIMENTAL
Intervention: Telehealth exercise intervention (90 min of exercise per week for 8 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Telehealth exercise intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed control group
Number of subjects: 60
Study: 34130753

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 32616033

Group type: EXPERIMENTAL
Intervention: Perceived availability of social support (appraisal support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived availability of social support (belonging support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived availability of social support (tangible support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived availability of social support (overall)
Number of subjects: 0
Study: 35195745

Group type: EXPERIMENTAL
Intervention: Interventional Ultrasound Skills Evaluation (IUSE) tool
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pass/fail score of the IUSE tool
Number of subjects: 18
Study: 32826319

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTA-EB-TATE at 1.17 ± 0.09 GBq/cycle
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTA-EB-TATE at 1.89 ± 0.53 GBq/cycle
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTA-EB-TATE at 3.97 ± 0.84 GBq/cycle
Number of subjects: 32
Study: 35614467

Group type: EXPERIMENTAL
Intervention: Triple therapy with budesonide/glycopyrronium/formoterol fumarate dihydrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One moderate exacerbation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ≥2 moderate exacerbations
Number of subjects: 0
Study: 34312262

Group type: EXPERIMENTAL
Intervention: Presence of social determinants of health (SDoH) insecurities
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: Functional capacity
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: Each insecurity (food, housing, financial)
Number of subjects: 2763
Study: 32838838

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 179918

Group type: COMPARATOR
Intervention: Anakinra
Number of subjects: 179918
Study: 35120178

Group type: EXPERIMENTAL
Intervention: Comfortable walking speed (cws)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Long stepping on the paretic side (p-long)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Long stepping on the non-paretic side (np-long)
Number of subjects: 41
Study: 34583969

Group type: EXPERIMENTAL
Intervention: Patient navigation
Number of subjects: 415

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 415
Study: 35860416

Group type: EXPERIMENTAL
Intervention: Transauricular vagus nerve stimulation (taVNS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sham stimulation (SS)
Number of subjects: 78
Study: 34628720

Group type: EXPERIMENTAL
Intervention: Single-dose napabucasin (80-1200 mg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single-dose napabucasin (240-1200 mg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single-dose napabucasin (240-720 mg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single-dose napabucasin
Number of subjects: 70
Study: 32223688

Group type: EXPERIMENTAL
Intervention: Direct rigid laryngoscope during suspension laryngoscopy (SL) procedures
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 64
Study: 36171512

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 34363478

Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise (60% to 80% of heart rate reserve, 3 times per week for 12 months)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual and customary care
Number of subjects: 250
Study: 32453996

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (intensive bi-manual treatment)
Number of subjects: 10
Study: 33439831

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 216

Group type: COMPARATOR
Intervention: Atosiban (competitive antagonist of oxytocin and vasopressin receptors)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Vasopressin (not administered)
Number of subjects: 216
Study: 32817130

Group type: EXPERIMENTAL
Intervention: gemcitabine/nab-paclitaxel plus pamrevlumab (Arm A, n=24)
Number of subjects: 37

Group type: COMPARATOR
Intervention: gemcitabine/nab-paclitaxel minus pamrevlumab (Arm B, n=13)
Number of subjects: 37
Study: 36421696

Group type: EXPERIMENTAL
Intervention: rhFGF-2 plus DBBM
Number of subjects: 32

Group type: COMPARATOR
Intervention: rhFGF-2
Number of subjects: 32
Study: 34334790

Group type: EXPERIMENTAL
Intervention: High-fat meal (61 g fat)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low-fat meal (10 g fat)
Number of subjects: 13
Study: 616117222

Group type: EXPERIMENTAL
Intervention: Conventional corneal collagen cross-linking (CXL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Accelerated corneal collagen cross-linking (CXL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Transepithelial by iontophoresis CXL
Number of subjects: 45
Study: 35653395

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus prednisolone (AAP)
Number of subjects: 1917

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 1917
Study: 32445277

Group type: EXPERIMENTAL
Intervention: Exhalation delivery system with fluticasone (EDS-FLU)
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo (EDS-PBO)
Number of subjects: 643
Study: 35427994

Group type: EXPERIMENTAL
Intervention: One-day educational program
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 184
Study: 33012276

Group type: EXPERIMENTAL
Intervention: 2 Feet 4 Life intervention (nurse-led, one hour/week for four consecutive weeks)
Number of subjects: 29
Study: 616855345

Group type: EXPERIMENTAL
Intervention: Epidural Anaesthesia
Number of subjects: 0
Study: 35378798

Group type: EXPERIMENTAL
Intervention: PPB in primiparas
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: PPB in multiparas
Number of subjects: 657
Study: 32601909

Group type: EXPERIMENTAL
Intervention: Postoperative complications graded by Clavien–Dindo classification (≥ C-D grade II)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Postoperative complications graded by Clavien–Dindo classification (≥ C-D grade III)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Intra-abdominal infectious complications (≥ grade II)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Intra-abdominal infectious complications (≥ grade III)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Any ≥ C-D grade III complication
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: All four definitions of complications
Number of subjects: 1191
Study: 35503499

Group type: EXPERIMENTAL
Intervention: IVT‐AFL‐2W
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IVT‐AFL‐4W
Number of subjects: 90
Study: 33082217

Group type: COMPARATOR
Intervention: Mechanical Insufflation-Exsufflation (MI-E)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mechanical Insufflation-Exsufflation with oscillations (MI-E + oscillations)
Number of subjects: 19
Study: 35565669

Group type: EXPERIMENTAL
Intervention: Individualized nutritional support to reach energy, protein, and micronutrient goals
Number of subjects: 645

Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 645
Study: 34246265

Group type: EXPERIMENTAL
Intervention: Intervention group (n=74)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (n=72)
Number of subjects: 146
Study: 35930728

Group type: EXPERIMENTAL
Intervention: 1 week MTX hold
Number of subjects: 178

Group type: COMPARATOR
Intervention: 2 week MTX hold
Number of subjects: 178
Study: 33190135

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.4 mg daily for 10 days)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Anticoagulants (meta-analysis)
Number of subjects: 73
Study: 36106651

Group type: EXPERIMENTAL
Intervention: Enhanced physical activity intervention (standard postoperative physical therapy plus goal setting, problem-solving, and motivational interviewing techniques)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard postoperative physical therapy only (control group)
Number of subjects: 45
Study: 32448693

Group type: EXPERIMENTAL
Intervention: Bupivacaine with epinephrine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 50
Study: 34288776

Group type: EXPERIMENTAL
Intervention: Suture group
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sutureless hydroclosure group
Number of subjects: 170
Study: 35339234

Group type: EXPERIMENTAL
Intervention: Astegolimab (490 mg subcutaneous every 4 weeks for 44 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (subcutaneous every 4 weeks for 44 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Astegolimab
Number of subjects: 0
Study: 33452047

Group type: EXPERIMENTAL
Intervention: Hypoallergenic medical wig
Number of subjects: 59

Group type: COMPARATOR
Intervention: Traditional medical wig
Number of subjects: 59
Study: 32987360

Group type: EXPERIMENTAL
Intervention: Action Observation plus Sonification (AOS) protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: External sensory cues
Number of subjects: 0
Study: 35660357

Group type: EXPERIMENTAL
Intervention: double Maddox test
Number of subjects: 25

Group type: COMPARATOR
Intervention: synoptophore
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Gracis torsionometer
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Harms screen
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Awaya test
Number of subjects: 25

Group type: COMPARATOR
Intervention: synoptophore vs Gracis torsionometer
Number of subjects: 25

Group type: COMPARATOR
Intervention: synoptophore vs Awaya test
Number of subjects: 25
Study: 32512380

Group type: EXPERIMENTAL
Intervention: Continuous ropivacaine (0.2%) at 10 mL/h for 48 h
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Continuous ropivacaine (0.2%)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Saline solution (0.9%)
Number of subjects: 150
Study: 33991350

Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg every 12 hours for 14 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bedaquiline (400 mg once daily for 2 weeks, followed by 200 mg twice a week for 46 weeks) with clarithromycin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bedaquiline monotherapy (400 mg once daily for 2 weeks, followed by 200 mg 3 times a week for 46 weeks)
Number of subjects: 16
Study: 35484186

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nasal cannula (NC)
Number of subjects: 26
Study: 34759229

Group type: EXPERIMENTAL
Intervention: Parylene-coated occluder
Number of subjects: 108

Group type: COMPARATOR
Intervention: Traditional nitinol-containing device
Number of subjects: 108
Study: 36409190

Group type: EXPERIMENTAL
Intervention: Sunflower Seed Oil (SSO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Liquid Vaseline (LV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no moisturizer)
Number of subjects: 90
Study: 32747650

Group type: EXPERIMENTAL
Intervention: vBMD of femoral head on non-fracture side
Number of subjects: 367

Group type: COMPARATOR
Intervention: vBMD of femoral head on fracture side
Number of subjects: 367
Study: 34169613

Group type: EXPERIMENTAL
Intervention: PDA-002 (low-dose 3 × 10^6 cells)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: PDA-002 (high-dose 30 × 10^6 cells)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32259301

Group type: EXPERIMENTAL
Intervention: Oral stimulation intervention
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control
Number of subjects: 211
Study: 34418665

Group type: EXPERIMENTAL
Intervention: CT plus cetuximab
Number of subjects: 243

Group type: COMPARATOR
Intervention: CT
Number of subjects: 243
Study: 32383285

Group type: EXPERIMENTAL
Intervention: Starter containing 160 g/kg CP (65 g/kg RUP, based on DM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Starter containing 180 g/kg CP (65 g/kg RUP, based on DM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Starter containing 200 g/kg CP (62 g/kg RUP, based on DM)
Number of subjects: 42
Study: 35640500

Group type: EXPERIMENTAL
Intervention: Nurse-Led Online Modules
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Online Modules
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 80
Study: 33124686

Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 11
Study: 32978541

Group type: EXPERIMENTAL
Intervention: C+P
Number of subjects: 1058

Group type: EXPERIMENTAL
Intervention: B+P
Number of subjects: 1058

Group type: EXPERIMENTAL
Intervention: PA
Number of subjects: 1058
Study: 34609110

Group type: EXPERIMENTAL
Intervention: Group 1 (Douro Litoral)
Number of subjects: 961

Group type: COMPARATOR
Intervention: Group 2 (Trás‐os‐Montes and Alto Douro)
Number of subjects: 961
Study: 33154177

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 4011

Group type: COMPARATOR
Intervention: Control (no GTN)
Number of subjects: 4011
Study: 32559039

Group type: EXPERIMENTAL
Intervention: Cancellous block allograft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Demineralized bone matrix (DBM) allograft
Number of subjects: 20
Study: 35911508

Group type: EXPERIMENTAL
Intervention: Simulated team assessment
Number of subjects: 477

Group type: COMPARATOR
Intervention: Real team assessment
Number of subjects: 477
Study: 32568464

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33800428

Group type: EXPERIMENTAL
Intervention: Abdominal Hypopressive Training (AHT) - 2 sessions of 30 min per week for 8 weeks
Number of subjects: 125
Study: 33085123

Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 1284

Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 1284
Study: 36180008

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Pain control beliefs
Number of subjects: 297

Group type: COMPARATOR
Intervention: Lower anxiety
Number of subjects: 297
Study: 33839801

Group type: EXPERIMENTAL
Intervention: Placental growth factor (PlGF) levels measured at baseline and at 24 and 34 weeks of gestation
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Healthy placenta (PlGF > 100) with suboptimal glycaemic control
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: sFlt‐1/PlGF ratio as a marker for healthy vs unhealthy placenta
Number of subjects: 157